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This is a topical review summarising the increasing evidence for an association between 1 
inadequate dietary antioxidant selenium intake and several disorders of reproduction. 2 
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Abstract 24 
Hiten D. Mistry PhD1, Fiona Broughton Pipkin DPhil2, Christopher W. G. Redman MD3 25 
& Lucilla Poston PhD1   26 
 27 
Selenium is an essential trace element of importance to human biology and health. 28 
Increasing evidence suggests that this mineral plays an important role in normal growth 29 
and reproduction in animals and humans, and selenium supplementation is now 30 
recommended as part of public health policy in geographical areas with severe selenium 31 
deficiency in soil. Here, the biological functions of selenium are addressed prior to a 32 
detailed review of associations between selenium status and reproductive health. In many 33 
countries, selenium dietary intake falls below the recommended nutrient intakes (RNIs) 34 
and is inadequate to support maximal expression of the selenoenzymes. Numerous reports 35 
implicate selenium deficiency in several reproductive and obstetric complications 36 
including male and female infertility, miscarriage, pre-eclampsia, fetal growth restriction, 37 
preterm labour, gestational diabetes and obstetric cholestasis. Currently, there is 38 
inadequate information from the available small intervention studies to inform public 39 
health strategies. Larger intervention trials are required to reinforce or refute a beneficial 40 
role of selenium supplementation in disorders of reproductive health. 41 
 42 
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Introduction 47 
Selenium was first discovered in 1817 by Jöns Jacob Berzelius when investigating the 48 
chemicals responsible for outbreaks of ill health amongst workers in a Swedish sulphuric 49 
acid plant, which had switched from expensive, imported sulphur to a local product 50 
(Oldfield, 1987). The local product contained a contaminant which he named Selēnē, 51 
after the Greek goddess of the moon (McKenzie et al., 1998). Selenium lies directly 52 
below sulphur in the periodic table and above tellurium, and has similar chemical 53 
properties, as it binds with equal affinity to metals and non-metals, both directly and 54 
hydrochemically (Bauer, 1997, Burk and Levander, 2006). In 1957, Klaus Schwarz 55 
proved that selenium is an essential nutrient necessary for both normal growth and 56 
reproduction in animals through experiments demonstrating that minute amounts of 57 
selenium were protective against a form of liver necrosis in laboratory rats fed diets 58 
containing torula yeast as a protein source (Schwarz and Foltz, 1957). Dietary 59 
supplementation, by means of selenium-enriched fertilizer in crop production, foliar 60 
spraying of staple crops such as rice or soya beans or, directly, through multi-vitamin 61 
supplementation is now an accepted practice in areas of selenium deficiency, worldwide 62 
(Oldfield, 2002, Yang et al., 1988).  63 
 64 
Selenium, amino acids and selenoproteins 65 
The amino acids methionine and cysteine contain sulphur in the form of thiol groups. 66 
Selenium can replace the sulphur to form selenomethionine ([Se]Met) or selenocysteine 67 
([Se]Cys or Sec) as a normal physiological process. A selenoprotein is any protein that 68 
includes a Sec or [Se]Met residue, which confers specific biological function. Dietary 69 
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selenium, initially taken up from the soil and concentrated by plants, is absorbed in the 70 
small intestine and incorporated into proteins by complex mechanisms which remain  71 
unclear (Reilly, 2006). The majority of selenium in the human diet is derived from 72 
[Se]Met in plant materials and both [Se]Met and Sec in animal products (Combs, 2001, 73 
Sunde, 1990). [Se]Met cannot be synthesised by higher animals, including humans, but 74 
after ingestion is non-specifically incorporated into proteins (e.g. haemoglobin, albumin) 75 
in place of methionine (Thomson et al., 1993). Selenophosphate is synthesised from 76 
selenide and ATP through the action of selenophosphate synthetase 2 (SEPHS2) and is 77 
the source of selenium from which Sec is then formed and co-translationally incorporated 78 
into selenoproteins at in-frame UGA codons. Sec has a lower pKa than Cys and is more 79 
nucleophilic, so is more reactive. During protein catabolism, Sec is rapidly broken down 80 
to elemental selenium, leaving no free pool of cellular Sec. This has a biological 81 
advantage, since Sec can react with oxygen, thioredoxin and thioredoxin reductase, 82 
giving rise to rapid NADPH oxidation and the formation of damaging reactive oxygen 83 
species (ROS) (Lu and Holmgren, 2009).  84 
 85 
The form in which selenium is present in food affects bioavailability and expression of 86 
the different selenoproteins. Organic selenium sources such as Se[Met] are more efficient 87 
at increasing the blood selenium concentration than inorganic selenium, such as selenite 88 
and selenate, but they appear to be equally adept at raising whole-blood glutathione 89 
peroxidase (GPx) activity in the long-term (Thomson et al., 1993). Bioavailability from 90 
the different selenium sources is also tissue dependent. Dietary protein is more effective 91 
than other sources in increasing measurable selenium status. High selenium consumption 92 
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leads to higher selenium content of proteins in the form of [Se]Met and Sec (Kohrle et al., 93 
2005).   94 
 95 
Selenite (SeO3
2−; inorganic form of selenium) crosses the plasma membrane, and reacts 96 
with cytoplasmic thiols in the reduction pathway; this forms selenide, which is then 97 
methylated, giving rise to methylated selenium derivatives that are excreted in urine, in 98 
expired air via the lungs and in faeces (Fig. 1) (Sunde, 1990, Ip, 1998). In humans these 99 
products of selenium metabolism are predominantly excreted in urine (Yang et al., 1989, 100 
Oster and Prellwitz, 1990).  The proportion of selenium intake excreted in this manner 101 
depends on dietary intakes; when this is high, urinary excretion will also be high and vice 102 
versa (Robinson et al., 1973, Thomson and Robinson, 1986, Oster and Prellwitz, 1990).   103 
 104 
There appears to be no homeostatic control of selenium absorption, which is unusual, in 105 
contrast, for example, to the complex regulation of iodine absorption (Kohrle et al., 2005, 106 
Reilly, 2006, Fairweather-Tait et al., 2010). Selenium is stored in the tissues in varying 107 
density: 30% in the liver, 30% in muscle, 15% in the kidney, 10% in the plasma, and the 108 
remaining 15% throughout other organs (Levander, 1987, Reilly, 2006).  Concentrations 109 
of free selenium are greatest in the renal cortex and pituitary gland, followed by the 110 
thyroid gland, adrenals, testes, ovaries, liver, spleen, and cerebral cortex (Drasch et al., 111 
2000, Kohrle et al., 2005).  112 
 113 
Selenoproteins, coded by twenty five selenoprotein genes in humans (Table 1) (Kryukov 114 
et al., 2003), exert multiple actions on endocrine, immune and inflammatory functions 115 
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(Beckett and Arthur, 2005, Thomson, 2004), in part because they have powerful 116 
antioxidant functions. The selenoenzymes have a Sec group at their active sites, which 117 
enables the formation of disulphide bonds (Burk and Levander, 2006); these function as a 118 
redox centre, participating in transfer of electrons between molecules (Flohe et al., 2000).  119 
Of the identified selenoproteins, three are iodothyronine deiodinases, which catalyse the 120 
removal of iodine from the 5 or 5’ positions of iodothyronine substrates. This regulates 121 
the activation and inactivation of thyroid hormones in all tissues (Beckett and Arthur, 122 
2005).  A further three are the thioredoxin reductase family (TrxR1, TrxR2 and TrxR3). 123 
Their substrates, thioredoxin and thioredoxin peroxidase do not contain selenium. These 124 
constitute a powerful dithiol-disulphide system that regulates the cellular redox state (Hill 125 
et al., 2003, Burk et al., 2003, Mostert et al., 2003) (Table 1). The Trx system also 126 
regulates other antioxidants (such as heme oxygenase-1, methionine sulphoxide 127 
reductases, ascorbate (Vit C), tocopherol (Vit E), ubiquinone (Q10)),  modulates several 128 
transcription factors (eg those involved in the maturation of p53) and regulates apoptosis 129 
and protein phosphorylation (Surai, 2006, Arner, 2009, Mostert et al., 2003). 130 
 131 
Of particular importance to reproduction and pregnancy are the 6 antioxidant GPxs which  132 
play a pivotal role in reducing hydrogen peroxide (H2O2) and lipid peroxides to harmless 133 
products (water and alcohols; Fig. 2), thereby dampening the propagation of damaging 134 
ROS (Rotruck et al., 1973, Brigelius-Flohe et al., 2003). This important pathway of 135 
cellular protection has been demonstrated in all mammalian tissue examined (Allan et al., 136 
1999, Knapen et al., 1999). As antioxidants, the GPxs help maintain membrane integrity, 137 
protect prostacylin production, and limit the propagation of oxidative damage to lipids, 138 
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lipoproteins, and DNA (Brigelius-Flohe et al., 2003). This pathway may also offer 139 
protection against development of several chronic diseases in which oxidative damage 140 
has been implicated, including atherosclerosis and certain cancers (Rayman, 2002, 141 
Combs, 2001, Brigelius-Flohe, 2008). However, the claims that selenium supplements 142 
contribute to the prevention of chronic disease currently lack substantial evidence based 143 
proof of efficacy. Indeed some of the larger trials have been negative, for  example the 144 
recent randomised, placebo-controlled cancer chemoprevention trial (selenium and 145 
vitamin E cancer prevention trial; SELECT) demonstrated no benefit of supplements of 146 
selenium (200 μ/day) and vitamin E (400 IU/day) in prevention of prostate cancer in a 147 
total of 35,533 men (Lippman et al., 2009).   148 
 149 
Dietary selenium 150 
Plant foods are the major dietary sources of selenium in most countries (Rayman, 2000, 151 
Combs, 2001). Surveys suggest that wheat is the most efficient selenium accumulator of 152 
the common cereals, and is one of the most important selenium sources for man (Lyons et 153 
al., 2003, Reilly, 2006). The content in food depends on the selenium content of the soil 154 
where plants are grown or animals are raised.  For example, the selenium content in the 155 
soil of the high plains of northern Nebraska and the Dakotas is very high, and the 156 
inhabitants have the highest selenium intakes in the US (Longnecker et al., 1991).  157 
Whether this degree of high intake has any positive health benefit is not known, but toxic 158 
effects supervene when intake exceeds ~ 850 g/day (Goldhaber, 2003).  159 
 160 
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Other foods make a substantial contribution to selenium intake in northern Europe, 161 
particularly meat, poultry, and fish (a total of about 36% in the UK) (Ministry Of 162 
Agriculture Fisheries and Food, 1997). Thus it has been predicted that vegetarians or 163 
vegans are at specific risk of selenium deficiency (Reilly, 2006, Judd et al., 1997), but 164 
this claim is not fully substantiated.   165 
 166 
Selenium incorporation into plants (initially), and then into animal tissues, not only 167 
depends on soil selenium content or geochemistry but also on soil pH, rainfall, land 168 
contour, the use of high-sulphur fertilisers and microbial activity; some bacteria can 169 
convert insoluble forms of selenium to soluble forms, which can then be taken up by 170 
plants (Diplock, 1993, Lyons et al., 2003).  Selenium tends to be more concentrated in the 171 
soils of the drier regions of the world, where soil tends to be more alkaline; in acidic 172 
poorly aerated soils, selenium is relatively unavailable to plants as it is present mainly as 173 
insoluble selenite complexes (Lyons et al., 2003, Reilly, 2006).  174 
 175 
In addition, in wetter regions, rain leaches selenium from the soil (Reilly, 2006). 176 
Selenium forms both inorganic and organic compounds and can be an oxidant as well as a 177 
reductant, an important factor in soil formation (Van Dorst and Peterson, 1984). 178 
Selenium’s chemical adaptability accounts for its widespread occurrence in soils, plants, 179 
animals and humans (Bauer, 1997).  Soil selenium concentrations range from 0.1 to more 180 
than 100 mg/Kg.  However, most soils contain between 1.0 to 1.5 mg/Kg (0.1-0.6 mg/Kg 181 
is considered deficient) (Lyons et al., 2003, Combs, 2001).    182 
 183 
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Selenium deficiency 184 
The optimal range of selenium intake to ensure biological benefit appears to be narrow 185 
and has still not been determined with certainty; however selenium deficiency has been 186 
studied in animals and humans (Van Vleet, 1980, Zachara et al., 1993a, Hurst et al., 187 
2010). Selenium deficiency as assessed by dietary intake and/or blood selenium 188 
concentrations has been identified in people inhabiting geographical regions notable for 189 
low soil selenium content, such as volcanic regions and in Finland and New Zealand, 190 
where the reported average selenium intake is approximately 30-40 µg/day (Levander and 191 
Burk, 1994, Thomson, 2004).  Animal selenium deficiency diseases have been routinely 192 
identified since the 1950s in livestock in countries that have low selenium soil conditions 193 
(Oldfield, 1997, Koller and Exon, 1986).   194 
 195 
Human selenium deficiency diseases have been recognised in China and Tibet (Moreno-196 
Reyes et al., 2003, Levander and Beck, 1997).  Keshan disease, a reversible endemic 197 
cardiomyopathy, is characterised by focal myocardial necrosis often associated with 198 
inflammatory infiltrates and calcification. The disorder is exclusively endemic in 199 
selenium-deficient rural areas of China e.g. Keshan (Beck et al., 2003) and 200 
supplementation with selenium tablets (as sodium selenite) in pregnancy (Moore et al., 201 
2000) provides highly effective protection against its development in susceptible women 202 
(Beck et al., 2003). 203 
 204 
In Northern Karelia (Finland) very low blood selenium concentrations have also been 205 
reported in men with a high risk of myocardial infarction (MTT Agrifood Research 206 
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Finland, 2005). Smoking further compromises selenium status by decreasing the serum 207 
concentration of selenium, and erythrocyte GPx activity (Northrop-Clewes and 208 
Thurnham, 2007, Duthie et al., 1993). Low selenium status may exacerbate disease 209 
progression in conditions not otherwise associated with selenium-deficiency e.g. human 210 
immunodeficiency virus (HIV) infection and hepatitis C virus, although the mechanism 211 
which affords protection by selenium is not known (Rayman, 2000).   212 
 213 
Dietary selenium intake in most parts of Europe is considerably lower than in the USA, 214 
mainly due to the European soils providing a poorer source of selenium (Thomson, 2004, 215 
Rayman, 2008). The reduction in consumption of wheat imported from the US in the 216 
European Union from the 1980s, as a result of the European Common Agricultural 217 
Policy, has been associated with a fall in daily selenium intake in the UK and other 218 
Western European countries over the last 20 years (Jackson et al., 2004).   219 
 220 
Assessments of requirements, adequacy and intakes of selenium have been reviewed 221 
previously in detail (Rayman, 2008, Thomson, 2004). The recommended daily 222 
allowances (RDA) for both men and women in USA is 55 µg/day, rising to 60 μg/day for 223 
pregnant women (Institute of Medicine, 2000). The UK is still using the 1991 reference 224 
nutrient intakes (RNI) of 75 µg/day for adult men, 60 µg/day for adult women and 75 225 
µg/day for lactating women (Department of Health, 1991).  The Department of Health 226 
reviewed whether selenium intake should be higher in 1998 and then again in 2009, but 227 
concluded that the original figures were still applicable (Department of Health, 1998, 228 
Department of Health, 2009). The World Health Organisation (WHO) set its normative 229 
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requirement estimate (NR) at a lower value of 40 µg/day for men and 30 µg/day for 230 
women (WHO/FAO/IAEA, 1996). The RDA/RNI values have been determined from the 231 
intake believed necessary to maximise the activity of the antioxidant GPx in plasma, 232 
whereas the NR is based on selenium intake needed to achieve two-thirds of maximum 233 
activity of erythrocyte GPx (Thomson, 2004).  234 
 235 
Selenium intake appears on average to be at or above the RDA in the US or Canada. A 236 
study in Maryland in 1981 reported that adults consumed an average of 81 µg/day of 237 
selenium (Welsh et al., 1981) and recently this has been estimated to be 108 µg/day for 238 
all US adults and 89 µg/day for women (Chun et al., 2010).  A Canadian survey in 1975 239 
reported intakes of 113 to 220 µg/day (Thompson et al., 1975); this was followed in 1998 240 
by a report indicating consumption of between 98-224 µg/day (Gissel-Nielsen, 1998). 241 
Conversely, the UK selenium dietary intake is generally below the RNI; a dietary survey 242 
published by the UK Government over the period 1994 to 1995 indicated that the average 243 
intake was as low as 30–40 μg per day (Ministry Of Agriculture Fisheries and Food, 244 
1997) a figure which had not improved in a survey conducted between 2008 and 2009 245 
(Department of Health, 2009). Although it has been argued that UK intakes are 246 
sufficiently low to warrant government intervention (Rayman, 2000), a UK government 247 
expert committee concluded in 1998 that intervention was, at that time, not warranted  248 
(Department of Health, 1998). Whether, this conclusion pertains to the dietary intake in 249 
2010 is uncertain and is worthy of investigation. 250 
Selenium toxicity 251 
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Whilst selenium deficiency is prevalent and therefore the more predominant health issue, 252 
there is also a moderate to high health risk of selenium toxicity,  first discovered in 253 
animals grazing in areas with high selenium content in the soil (Twomey et al., 1977). 254 
Chronic toxicity of selenium in humans results in selenosis, a condition characterised by 255 
brittleness or loss of hair and nail loss, gastrointestinal problems, rashes, garlic breath 256 
odour, and nervous system abnormalities (Yang et al., 1983).  In China, it has been 257 
reported that selenosis occurs with increased frequency in people who consumed 258 
selenium at levels above 850 g/ day (Yang and Zhou, 1994).  The Institute of Medicine, 259 
USA, has set a tolerable upper intake level for selenium at 400 g/day for adults to 260 
prevent the risk of developing selenosis (Institute of Medicine, 2000). The European 261 
Commission and WHO have proposed the lower daily upper limit of 300 g/day for 262 
adults (European Commission Health and Consumer Protection Directorate, 2000, 263 
WHO/FAO/IAEA, 1996). 264 
 265 
Selenium in Reproductive Health 266 
The role that selenium plays in both male and female reproduction is well recognised in 267 
animal husbandry (Reilly, 2006). Selenium is essential for male fertility, being required 268 
for testosterone biosynthesis and the formation and normal development of spermatozoa 269 
(Behne et al., 1996, Flohe, 2007). Studies using selenoprotein P-knockout mice support a 270 
requirement for selenium in testicular function (Hill et al., 2003) and animals fed 271 
selenium-deficient diets show impaired spermatozoan motility with flagellar defects 272 
localised primarily to the midpiece, decreasing the chance of fertilisation (Behne et al., 273 
1996, Wu et al., 1973). 274 
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 275 
Testicular tissue contains high concentrations of selenium, predominantly as GPx4 and 276 
this provides the pivotal link between selenium, sperm quality and male fertility since 277 
GPx4 is a fundamental determinant of the architecture of the spermatozoan midpiece 278 
(Beckett and Arthur, 2005, Knapen et al., 1999), and is considered to shield developing 279 
sperm cells from oxidative DNA damage (Ursini et al., 1999, Safarinejad and Safarinejad, 280 
2009). ROS have been implicated in male infertility because, through attack of the 281 
spermatozoa membrane, sperm viability is decreased.  282 
 283 
Some evidence suggests that increasing selenium dietary intake increases antioxidant 284 
GPx activity, thereby increasing male fertility (Irvine, 1996). Bleau et al’s study in 1984 285 
was one of the first indications, in humans, that selenium deficiency may be related to 286 
male fertility, reporting an optimal range between 50 - 60 μg/ml in semen and a positive 287 
correlation between sperm count and semen selenium concentration in 125 men from 288 
couples being investigated for infertility (Bleau et al., 1984). In Scotland (where mean 289 
selenium intakes are below requirements, ~30-40 µg per day) a placebo-controlled 290 
randomised control trial (RCT) of 64 men demonstrated that sperm quality and fertility 291 
improved after selenium supplementation (Scott et al., 1998). A placebo-controlled RCT 292 
from Tunisia of 54 infertile and 54 men on placebo also demonstrated the beneficial 293 
effects of a combination of vitamin E (400 mg) and selenium (225 μg) daily supplements 294 
for 3 months on improving sperm motility (Keskes-Ammar et al., 2003). In another recent 295 
placebo–controlled RCT in Iran of 468 infertile men, supplementation with 200 μg 296 
selenium orally daily for 26 weeks improved semen quality including sperm count, 297 
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concentration, morphology and motility, as well as plasma and semen selenium 298 
concentrations (Safarinejad and Safarinejad, 2009). A recent review of the effect of oral 299 
antioxidants (including selenium) on male subfertility concluded that supplementation 300 
could improve sperm quality and/or pregnancy rates but recommended that large 301 
adequately powered trials using individual antioxidants are required (Ross et al., 2010). 302 
 303 
Data regarding selenium and female fertility are sparse. Paszkowski et al, completed a 304 
study of 135 follicular fluid samples collected from 115 patients during transvaginal 305 
oocyte retrieval; patients with unexplained infertility had significantly decreased 306 
follicular selenium concentrations compared to those with tubal infertility or a known 307 
male related cause of infertility (Paszkowski et al., 1995). A recent case-controlled study 308 
from Turkey also found lower serum and follicular fluid selenium concentrations in 30 309 
women undergoing IVF treatment compared to 13 age-matched non-pregnant control 310 
women (Ozkaya et al., 2010). Another rather indirect indication of a role for selenium in 311 
fertility comes from a small study of women with a history of unexplained infertility. In 6 312 
of the 12 women investigated the red-cell magnesium content failed to normalises after 4 313 
months of magnesium supplementation and was associated with a lower red-cell GPx 314 
activity than that observed in the remaining 6 women whose red-cell magnesium regained 315 
normality (Howard et al., 1994). Subsequent supplementation with magnesium and 316 
selenium for 2 months achieved red-cell magnesium normalisation and increased red-cell 317 
GPx activity and the women later (within 8 months) conceived with a healthy pregnancy 318 
outcome (Howard et al., 1994). The authors theorised  that failure to maintain cellular 319 
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magnesium homeostasis result from ROS induced cell permeability secondary to poor 320 
selenium status (Howard et al., 1994).  321 
 322 
A combination of insulin, transferrin and selenium (ITS) is widely used as an adjuvant 323 
mixture in culture media for studies of ovarian and early pregnancy tissue, including 324 
human pre-antral follicles (Roy and Treacy, 1993, Abedelahi et al., 2010) or human fetal 325 
ovaries (Roig et al., 2006). The addition of selenium is reported to increase total 326 
antioxidant capacity and GPx activity, and decrease the levels of ROS, thus improving 327 
the in vitro development of follicles (Abedelahi et al., 2010). 328 
 329 
In reinforcing the antioxidant properties of selenium, these studies highlight a potential 330 
role in female reproductive function. As concluded in a recent review, the relationship 331 
between oxidative stress, decreased female fertility, and selenium deficiency is an 332 
association which warrants further research activity (Ruder et al., 2009).  333 
 334 
Selenium and disorders of pregnancy 335 
Miscarriage 336 
Miscarriage, a clinically detectable pregnancy that fails to progress past 24 weeks’ 337 
gestation, occurs in 10-20% of all pregnancies (Bradley and Hamilton-Fairley, 1998). 338 
Genetic (chromosomal) abnormalities explain at least half of all miscarriages. Although 339 
anatomical, endocrine, immune, infective and thrombophilic conditions are other possible 340 
causes, most chromosomally normal miscarriages remain unexplained or idiopathic 341 
(Hirschfeld et al., 2007).  342 
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 343 
Miscarriages have been associated with selenium deficiency in veterinary practice (Stuart 344 
and Oehme, 1982),  and selenium supplements prevent early pregnancy loss in sheep 345 
(Hidiroglou, 1979).  In humans, a UK observational study reported significantly lower 346 
serum selenium concentrations in 40 women with 1st trimester miscarriage compared to 347 
40 age-matched non-pregnant and 40 healthy gestation-matched women (Barrington et 348 
al., 1996). A similar finding was reported in another observational study from Turkey of 349 
20 women with 1st trimester miscarriage compared to controls (Kocak et al., 1999). Red-350 
cell and hair selenium concentrations are also reported to be lower in women with 351 
recurrent miscarriage (Al-Kunani et al., 2001, Kumar et al., 2002). Early pregnancy loss 352 
has been linked to reduced antioxidant protection of biological membranes and DNA and 353 
also to low concentrations of the selenium-dependent GPx (Barrington et al., 1997, 354 
Zachara et al., 2001, Jauniaux et al., 2006), and although speculative, women with 355 
recurrent pregnancy loss could potentially benefit from optimisation of selenium status.  356 
 357 
Normal Pregnancy 358 
During normal pregnancy, the selenium requirement is increased as a result of demands 359 
from the growing fetus (Smith and Picciano, 1986) and both inorganic and organic forms 360 
of selenium cross the placenta in humans and experimental animals (Shennan, 1987, 361 
Shennan, 1988, Nandakumaran et al., 2003, Nandakumaran et al., 2002). The RDA of 362 
selenium in pregnancy in the USA, calculated based on a fetal deposition of 4 μg/ day 363 
throughout pregnancy, is 60 μg/ day (Institute of Medicine, 2000). 364 
 365 
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In countries such as Poland and Yugoslavia where soil selenium content and dietary 366 
intake are low, maternal selenium concentrations and GPx activity fall during pregnancy, 367 
being the lowest at delivery compared with non-pregnant controls (Mihailovic et al., 368 
2000, Zachara et al., 1993b). In contrast, in areas of very high soil selenium content e.g. 369 
South Dakota, it would appear that there is no gestational trend in serum selenium 370 
concentrations (Kundu et al., 1985). Babies generally have lower selenium concentrations 371 
compared to the mother (Gathwala et al., 2000, Mistry et al., 2008), which might be 372 
anticipated as selenium is transported via the placenta across a concentration gradient via 373 
an anion exchange pathway, (Shennan, 1987, Shennan, 1988).   374 
 375 
 376 
Pre-eclampsia 377 
Pre-eclampsia (de novo proteinuric hypertension) is estimated to occur in ~3% of all 378 
pregnancies and is a leading cause of maternal and perinatal mortality and morbidity in 379 
the Western world (Sibai et al., 2005, Steegers et al., 2010); together with other 380 
hypertensive disorders of pregnancy, pre-eclampsia is responsible for approximately 381 
60,000 maternal deaths each year (Broughton Pipkin, 2001) and increases perinatal 382 
mortality five-fold (Roberts and Lain, 2002). Optimal outcome for the mother and child 383 
often dictates that the infant is delivered early leading to increased preterm delivery and 384 
low infant birthweight rates. Placental and maternal systemic oxidative stress are 385 
components of the syndrome (Poston, 2004) and contribute to a generalised maternal 386 
systemic inflammatory activation (Redman and Sargent, 2003). Placental ischaemia-387 
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reperfusion injury has been implicated in excessive production of ROS, causing release of 388 
placental factors that mediate the inflammatory responses (Hung and Burton, 2006).  389 
 390 
Endothelial cell dysfunction has been implicated in the many clinical manifestations of 391 
pre-eclampsia including hypertension and altered haemodynamics (Hubel, 1999, Poston, 392 
2006). There is increased interest in the association between selenium status and pre-393 
eclampsia. In light of the association between oxidative stress and the prevalence of low 394 
dietary selenium status worldwide, several studies have suggested that selenium 395 
deficiency may be linked to pre-eclampsia.  396 
 397 
The recent appreciation that nutrient-gene interactions may play a major role in 398 
manifestation of hereditary disease traits (Hesketh, 2008) could be of relevance to the 399 
association between selenium status and pre-eclampsia. Several genes which encode 400 
selenoproteins demonstrate functional polymorphisms. Examples include GPx3, 401 
functional polymorphisms of which decrease transcriptional activation, gene expression 402 
and plasma protein activities (Voetsch et al., 2007a, Voetsch et al., 2007b). A single 403 
nucleotide polymorphism within the 3’UTR of the GPx4 gene (GPx4c718t) affects GPx 404 
protein concentration and activity but also has differential effects on GPx3 and GPx1 405 
when selenium supplementation is stopped (Meplan et al., 2008).  406 
 407 
Selenoprotein S (also known as SEPS1 or VIMP), which contains a Sec residue at its 408 
active site, is an anti-inflammatory protein that acts primarily to limit the damaging 409 
consequences of endoplasmic reticulum stress (Ye et al., 2004), which has recently been 410 
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suggested to contribute to the development of pre-eclampsia (Burton et al., 2009). A 411 
polymorphic variant in the SEPS1 locus has been associated with increased 412 
cardiovascular disease morbidity in Finnish females (Alanne et al., 2007) and a 105G>A 413 
promoter polymorphism associated with reduced function has been defined and is 414 
significantly but not strongly associated with pre-eclampsia (Moses et al., 2008). Given 415 
that pre-eclampsia has a familial component (Cincotta and Brennecke, 1998, Lie et al., 416 
1998, Chappell and Morgan, 2006), a high prevalence of these polymorphisms could, in 417 
association with selenium deficiency be a major determinant of impaired antioxidant 418 
defence in this disorder, through altered selenoprotein activity, and thereby contribute to 419 
development of the disease through  ‘nutrigenomic’ pathways. Genome wide association 420 
studies of adequate size, such as that currently underway (Wellcome Trust case-control 421 
consortium (WTCCC3) – pre-eclampsia; 422 
http://www.wtccc.org.uk/ccc3/projects/ccc3_eclampsia.shtml) will be valuable in 423 
determination of the prevalence of these and similar functional polymorphisms in women 424 
affected by pre-eclampsia.  425 
 426 
In the UK, where selenium dietary intake is low, our group and others have reported 427 
selenium concentrations in pre-eclamptic pregnancies to be reduced in sera from the  428 
mother (Atamer et al., 2005, Mistry et al., 2008) and fetus (Mistry et al., 2008) as well as 429 
in amniotic fluid (Dawson et al., 1999) and in toenails (reflecting longer term selenium 430 
stores) (Rayman et al., 2003), when compared to normal pregnant controls. A recent 431 
retrospective study from Iran reported lower plasma selenium concentrations in 40 pre-432 
eclamptic compared to 40 control women (Maleki et al., 2011). Conversely, others have 433 
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shown no differences (Rayman et al., 1996) and in one study from the USA, higher sera 434 
selenium concentrations have been reported in women with pre-eclampsia (Mahomed et 435 
al., 2000).  However,  a reported lack of sensitivity of the assays used (Rayman et al., 436 
1996), or dependence of  the maternal leucocyte selenium content in estimation of 437 
selenium status  (Mahomed et al., 2000) may confound interpretation of these studies. 438 
 439 
Selenoprotein GPx activities in both maternal and cord plasma have also been shown to 440 
be lower in pre-eclamptic pregnancies. A retrospective study of plasma taken from 25 441 
pre-eclamptic and 15 healthy pregnant Turkish women in their 3rd trimester observed 442 
significantly lower GPx levels in pre-eclampsia compared to controls  (Yildirim et al., 443 
2004).  A similar study, also from Turkey, retrospectively collected maternal blood just 444 
before delivery, from 30 mild pre-eclamptic (defined as blood pressure > 140/90 mm Hg 445 
plus > 300 mg/24 hours proteinuria); 30 severe pre-eclamptic (defined as > 160/110 mm 446 
Hg plus 5 g proteinuria in 24 hours) and 30 normal pregnant women. This study reported 447 
lower concentrations of GPx in both pre-eclampsia groups compared to the controls 448 
(Bulgan Kilicdag et al., 2005).  449 
 450 
Several other retrospective studies from the USA (Wang and Walsh, 1996, Walsh and 451 
Wang, 1993), Turkey (Atamer et al., 2005) and Australia (Vanderlelie et al., 2005) of 452 
placental tissue collected from normal pregnancy and pre-eclampsia report a reduction in 453 
GPx activity in pre-eclampsia. Our group recently conducted a retrospective cross-454 
sectional study in the UK of 25 pre-eclamptic women and 27 healthy controls, in which 455 
maternal blood samples were collected before delivery,  as well as cord blood and 456 
 22 
  
placental tissue immediately after delivery (Mistry et al., 2008).  Plasma concentrations 457 
of thiobarbituric acid reactive substances (TBARS; a marker for lipid peroxidation) were 458 
increased in maternal and cord plasma in the pre-eclamptic group.  Moreover, total GPx 459 
activity in plasma and in placental tissue were significantly reduced in pre-eclampsia 460 
(Mistry et al., 2008). Further prospective, longitudinal studies are required to elucidate a 461 
‘cause or effect’ relationship. If selenium deficiency is confirmed in women suffering 462 
from pre-eclampsia, and this continues to be linked with GPx inadequacy, selenium 463 
supplementation in pregnancy may be of benefit in prevention or amelioration of pre-464 
eclampsia, a hypothesis which is currently being addressed in a RCT (see below). 465 
 466 
Some small studies have attempted to assess the influence of selenium supplementation 467 
on the incidence of pregnancy related hypertensive disorders, Han et al., conducted a 468 
small placebo-controlled RCT in Beijing, China, a population with a high risk of 469 
pregnancy-induced hypertension (PIH) and between 26%-27% and selenium deficiency.  470 
52 women with known risk factors for PIH  were randomised to selenium (100 μg/day) 471 
for 6-8 weeks during late pregnancy, and 48 were randomised to placebo (Han and Zhou, 472 
1994). The selenium supplemented group had a reduced incidence of development of PIH 473 
(7.7%; 4/52) compared to the placebo group (22.7%; 11/48), and significantly increased 474 
maternal and cord blood selenium concentrations. Another very small prospective 475 
double-blind, placebo-controlled RCT study in Indonesia, reported lower rates of pre-476 
eclampsia and/or PIH in  women who were at increased risk of developing these 477 
conditions, after supplementation (n = 29) with a range of antioxidants and cofactors 478 
including selenium (100 μg) (Rumiris et al., 2006).  Neither study adequately addressed 479 
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the role of supplementation on the incidence of pre-eclampsia. Recently however, Tara et 480 
al, investigated selenium supplementation of Iranian women in their first trimester (100 481 
μg selenium per day) in a small pilot RCT and concluded that supplementation may be 482 
associated with a lower frequency of pre-eclampsia although this didn’t quite reach 483 
statistical significance (Tara et al., 2010). 484 
 485 
There is no current consensus on the optimal dietary selenium supplement for use in 486 
clinical supplementation, since bioavailability and effects on expression of the various 487 
selenoproteins depend on the form of selenium product used (Rayman, 2008). A small 488 
UK based RCT of selenium supplementation (selenium in pregnancy; SPRINT) 489 
conducted by the Universities of Surrey and Oxford is ongoing. Although not powered to 490 
demonstrate clinical benefit this study is designed to assess the impact of selenium 491 
supplements on pre-eclampsia related biomarkers. Unselected primiparae are recruited 492 
between 12 and 16 weeks’ gestation. The active treatment is 60 g a day of selenium-493 
enriched yeast, which is intended to normalise blood selenium concentrations. Most 494 
selenium in selenium-enriched yeast is in the form of [Se]Met, and supplementation with 495 
this yeast has, in the majority of reported studies been shown to increase the activity of 496 
the selenoenzymes (Rayman, 2004). If successful, a larger multicentre RCT adequately 497 
powered to detect differences in rates of pre-eclampsia will be needed to assess potential 498 
clinical benefit. 499 
 500 
 501 
Preterm labour 502 
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Preterm labour (labour < 37 weeks’ gestation) is a major cause of perinatal morbidity and 503 
mortality occurring in 6-7% pregnancies in the developed world and up to 25% in 504 
undeveloped countries (Steer, 2005) and is likely to be of complex origin. Amongst the 505 
few studies to have investigated selenium and preterm labour, Dobrzynski et al from 506 
Poland reported lower maternal selenium concentrations and reduced maternal and cord 507 
plasma GPx activities in 46 women who delivered preterm compared to 42 women 508 
delivering at term (Dobrzynski et al., 1998). The low selenium concentrations and GPx 509 
activities in the blood of the preterm infants were proposed to contribute to respiratory 510 
distress syndrome, retinopathy of prematurity, increased haemolysis or other prematurity 511 
related conditions (Dobrzynski et al., 1998). A study from Germany of formula-fed 512 
preterm infants (gestational age < 32 weeks, birthweight < 1500 g) observed significantly 513 
lower mean plasma selenium concentrations compared to healthy term infants who were 514 
also formula-fed (Sievers et al., 2001). Another recent report from Iran of 30 preterm 515 
(gestational age <34 weeks) and 30 term infants (gestation age >37 weeks) also revealed 516 
significantly lower serum selenium concentrations in the preterm infants compared to 517 
term controls (Iranpour et al., 2009). A study from the USA of 13 preterm and 15 term 518 
infants found no differences in maternal plasma selenium concentrations, but also 519 
reported that preterm infants had lower selenium concentrations compared to term infants 520 
(Mask and Lane, 1993). As might be anticipated, the daily dietary selenium intake was 2-521 
3 times higher (96-134 μg) than in the subjects reported in the Polish population 522 
(Dobrzynski et al., 1998). Evidently, population selenium intake may explain some 523 
variation between studies.  524 
 525 
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Preterm premature (pre-labour) rupture of membranes (PPROM) is a major initiating 526 
factor in preterm labour and affects 10-12% of all pregnancies. PPROM is defined as 527 
premature rupture of chorioamniotic membranes before the onset of labour and is 528 
associated worldwide with increased rates of neonatal and maternal morbidity and 529 
mortality (Parry and Strauss, 1998, ACOG, 2007). Increased generation of ROS as well 530 
as antioxidant deficiency may play a important role in the pathophysiology of PPROM, 531 
which has been associated with enhancement of collagen degradation and subsequent 532 
damage to fetal membrane integrity (Wall et al., 2002, Woods, 2001, Woods et al., 2001). 533 
A potential association with selenium has been highlighted through a recent small 534 
prospective double blind, placebo-controlled RCT in Iran randomised 166 primigravid 535 
pregnant women in the first trimester of pregnancy to receive 100 μg/day selenium or 536 
placebo until delivery (Tara et al., 2010). The supplemented group demonstrated a 537 
significant increase in the mean serum selenium concentration and a reduction in the 538 
incidence of PPROM (Tara et al., 2010).  539 
 540 
Fetal growth restriction 541 
Fetal growth restriction or delivery of a small for gestational age infant (SGA) is defined 542 
as an individualised birthweight ratio below the 10th percentile, and is associated with 543 
increased perinatal mortality and morbidity (Cetin et al., 2004). Some studies of SGA 544 
deliveries report a reduced placental selenium concentrations (Klapec et al., 2008), 545 
whereas others report higher (Osada et al., 2002, Zadrozna et al., 2009) or unchanged 546 
concentrations (Llanos and Ronco, 2009). Strambi et al., demonstrated that in 81 SGA 547 
(both term and preterm) retrospective cases from Italy, infant plasma selenium 548 
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concentrations were significantly lower compared to adequate-for-gestational age (AGA) 549 
infants (Strambi et al., 2004). Again geographical differences may explain the difference 550 
between the selenium status in the different studies. 551 
A recent investigation by our group in a cohort of adolescent pregnant women from two 552 
UK inner cities (Baker et al., 2009) found lower plasma selenium concentrations in 553 
mothers who delivered SGA infants compared to mothers who delivered AGA infants 554 
(Mistry et al., 2010). A recent series of papers from North Dakota State University 555 
suggest some protective effect of high selenium intake in nutrient-restricted pregnant 556 
ewes on fetal birthweight and placental development (Lekatz et al., 2010). We are not 557 
aware of any ongoing studies investigating maternal and fetal selenium status in relation 558 
to fetal growth restriction although these observations would warrant a larger prospective 559 
study especially focussing on adolescent pregnant women and those residing in selenium-560 
deficient populations. 561 
 562 
Obstetric cholestasis 563 
Obstetric cholestasis (OC) is a serious complication of pregnancy and affects 564 
approximately 4,500 women per year in the UK. Affected women develop itching, 565 
otherwise-unexplained elevation of plasma liver enzymes and of serum bile acids and 566 
occasionally jaundice. OC is associated with an increased risk of premature delivery and 567 
fetal distress and is believed to be an important cause of stillbirth (Gurung et al., 2009).  568 
 569 
Selenium was first linked with OC in 1987 when Kauppila et al demonstrated that serum 570 
selenium concentrations were significantly lower in 12 Finnish women with OC when 571 
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compared to 12 normal pregnancies during the last trimester and postpartum (Kauppila et 572 
al., 1987).  Furthermore they also showed GPx activities to be decreased, showing a 573 
significant positive correlation with selenium concentration (Kauppila et al., 1987). Thus, 574 
it has been hypothesised that inadequate antioxidant protection may lead to hepatocyte 575 
oxidative damage and reduce excretion of bile (Akerboom et al., 1984). These initial 576 
results have been confirmed and extended in a study of 21 women with OC in Chile, also 577 
showing that the decrease in prevalence of OC in Chile during the last decade coincided 578 
with an increase in plasma selenium concentrations (Reyes et al., 2000). 579 
 580 
Gestational diabetes mellitus 581 
Gestational diabetes mellitus (GDM) is one of the more common diseases in pregnancy, 582 
affecting between 2% and 5% of pregnant women and is associated with birthweights 583 
above the 90th centile, increased levels of primary Caesarean deliveries and neonatal 584 
hypoglycaemia (Gilmartin et al., 2008). GDM is defined as a deficient insulin supply 585 
relative to the increased demands that are characteristic of pregnancy (Metzger et al., 586 
2007).  The causes are not known but are closely related to a constitutional risk of type 2 587 
diabetes in later life and strongly associated with obesity. A significant proportion of 588 
GDM women develop type 2 diabetes 5-16 years after pregnancy (17-63% risk) (Kjos et 589 
al., 1995, O'Sullivan and Mahan, 1964, Mestman et al., 1972).   590 
 591 
A link between selenium and glucose metabolism has been observed previously in animal 592 
studies (Becker et al., 1996, McNeill et al., 1991, Ezaki, 1990) and selenium administered 593 
to streptozotocin-diabetic rats showed a restoration of glycemic control and a 594 
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modification of the activity of a range of enzymes involved in hepatic glycolysis and 595 
glyconeogenesis (Becker et al., 1996). Several studies from China, Kuwait, Turkey and 596 
the USA have shown a decrease in maternal plasma selenium concentrations in women 597 
with GDM (Tan et al., 2001, Hawkes et al., 2004, Kilinc et al., 2008, Al-Saleh et al., 598 
2004). Bo et al completed a retrospective study investigating selenium intakes through 599 
dietary questionnaires in 504 pregnant women (210 with hyperglycemia and 294 healthy 600 
controls) as well as measuring serum concentrations in a second cohort (71 601 
hyperglycemic and 123 controls) (Bo et al., 2005). A lower dietary intake of selenium 602 
was observed in the hyperglycaemic group and in the second cohort, selenium 603 
concentrations were significantly lower in the women who had impaired glucose 604 
tolerance; both dietary intakes and selenium concentration were negatively associated 605 
with gestational hyperglycemia in a multiple regression model (odds ratio 0.97 and 0.92 606 
respectively) (Bo et al., 2005).  607 
 608 
An inverse relationship between selenium concentrations and blood glucose 609 
concentrations has also been observed (Kilinc et al., 2008, Tan et al., 2001, Hawkes et al., 610 
2004), but was not accompanied by changes in insulin (Hawkes et al 2004) suggesting 611 
that selenium may affect glucose metabolism downstream from insulin, or possibly 612 
through independent energy regulating pathways such as thyroid hormones (Hawkes et 613 
al., 2004). This relationship is unique to pregnancy: diabetes in non-pregnant subjects is 614 
associated with higher blood selenium concentrations (Laclaustra et al., 2009).  615 
 616 
Conclusions 617 
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There are wide differences in selenium intake across diverse populations, depending on 618 
the selenium content of the soil, and hence the selenium content in staple foodstuffs, as 619 
well as on variations in individuals’ diets. Both deficiency and excess are damaging to 620 
health. In turn, varying intakes are associated with differences in selenoprotein and 621 
selenoenzyme expression in different tissues. This must be taken into account when 622 
comparing data from different countries or populations.  Evidently, the balance between 623 
intake, tissue concentration and selenoenzyme synthesis is a very delicate one. This 624 
review illustrates the potential influence that selenium status has on many disorders 625 
relating to both animal and human reproduction and pregnancy. While persuasive 626 
evidence already exists to suggest that additional selenium would be beneficial in some of 627 
these disorders, results from intervention trials underway or planned have the potential to 628 
reinforce or refute the argument for increasing selenium intake.  629 
 630 
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Figure legends 1110 
 1111 
Figure 1: Selenium metabolic pathway.  This diagram illustrates how selenoproteins can 1112 
be produced in the body from a variety of selenium sources.  Glutathione (GSH) is 1113 
considered to be the main component of the selenium metabolism pathway taking part in 1114 
the first of a series of reduction reactions which convert selenite to hydrogen selenide 1115 
(H2Se). [Se]Met: selenomethionine; [Se]Cys: selenocysteine.  Adapted from (Sunde, 1116 
1990, Ip, 1998, Patrick, 2004). 1117 
 1118 
Figure 2: Major pathways of reactive oxygen species generation and metabolism. 1119 
Superoxide can be generated by specialized enzymes, such as the xanthine or NADPH 1120 
oxidases, or as a byproduct of cellular metabolism, particularly the mitochondrial electron 1121 
transport chain. Superoxide dismutase (SOD) then converts the superoxide to hydrogen 1122 
peroxide (H2O2) which has to be rapidly removed from the system. This is generally 1123 
achieved by catalase or peroxidases, such as the selenium dependent glutathione 1124 
peroxidases (GPxs) which use reduced glutathione (GSH) as the electron donor. 1125 
